Glutamine (Gln) is considered the preferred precursor for the neurotransmitter pool of glutamate (Glu), the major excitatory transmitter in the mammalian CNS. Here, an activity-regulated, high-affinity Gln transport system is described in developing and mature neuron-enriched hippocampal cultures that is potently inhibited by riluzole (IC 50 1.3 AE 0.5 lM), an anti-glutamatergic drug, and is blocked by low concentrations of 2-(methylamino)isobutyrate (MeAIB), a system A transport inhibitor. K + -stimulated MeAIB transport displays an affinity (K m ) for MeAIB of 37 AE 1.2 lM, saturates at~200 lM, is dependent on extracellular Ca
Excessive pre-synaptic Glu release is involved in several acute and chronic neurodegenerative diseases (Benveniste et al. 1984; Obrenovitch and Urenjak 1997; Puel et al. 1998; Dudek and Sutula 2007; Kostandy 2012; Dorsett et al. 2016) . Riluzole is a benzothiazole anticonvulsant that was shown many years ago to be neuroprotective in numerous conditions of excessive synaptic Glu release including global and focal cerebral ischemia (Pratt et al. 1992; Doble 1996; Stutzmann et al. 1997; Kanthasamy et al. 1999) . Riluzole has received renewed attention as an anti-glutamatergic agent because of novel methods that increase its brain penetration (Verma et al. 2016) , the reported beneficial effects of riluzole in animal models of Alzheimer's disease (Hunsberger et al. 2015; Mokhtari et al. 2016; Pereira et al. 2016) , and riluzole derivatives with increased anti-convulsant properties (Coleman et al. 2015) . Today, riluzole is registered under the trade name Rilutek for the treatment of amyotrophic lateral sclerosis. Riluzole exhibits various pharmacological activities, the most potent of which is inhibition neuronal Na + channels at concentrations of 1-50 lM (Benoit and Escande 1991; Herbert et al. 1994; Song et al. 1997; Stefani et al. 1997; Prakriya and Mennerick 2000; Spadoni et al. 2002) , which would reduce neuronal circuit activity and Ca 2+ -dependent synaptic Glu release (Cheramy et al. 1992; Martin et al. 1993; Wang et al. 2004) . Na + -dependent Gln import into synapses from astrocytes to replenish synaptic Glu stores released is a potential novel target to reduce excessive synaptic Glu release (Kanamori and Ross 2013; Tani et al. 2014; Marx et al. 2015) . Direct functional evidence for activity-regulated Ca 2+ -dependent Gln transport in hippocampal neurons is, however, lacking.
The concept of Glu/Gln cycling for replenishment of neurotransmitter Glu pools originated from 13 C-and 15 N-NMR determinations in vivo (Sibson et al. 2001; Rae et al. 2003) and 'classic' biochemical experiments in vitro where it was shown that 3 H-Gln was a preferred precursor for synaptic Glu released in various neuronal preparations including the hippocampus (Hamberger et al. 1979; Reubi 1980) . Activity-induced modulation of synaptic efficacy Bacci et al. 2002) and glutamatergic epileptiform activity (Tani et al. 2010; Kanamori and Ross 2011) requires transport of Gln that is significantly reduced by inhibition of Gln synthesis in astrocytes or by application of 2-(methylamino)isobutyrate (MeAIB) that blocks Gln import into neurons. MeAIB is a competitive and reversible inhibitor of the low-affinity (K m~0 .5 mM) Na + -coupled neuronal Gln transporters SNAT1 and SNAT2 (Mackenzie and Erickson 2004 ). An activity-induced electrogenic Gln transporter has recently been reported that is inhibited by high concentrations (20 mM) of MeAIB (Billups et al. 2013) suggesting that activity-regulated Gln/MeAIB transport in the specialized calyx of Held synapse is mediated by SNAT1 or SNAT2 (Blot et al. 2009; Marx et al. 2015) . Although SNAT1 and SNAT2 are localized to CNS neurons, they are not expressed in axon terminals in the cerebral cortex or hippocampus (Mackenzie et al. 2003; Conti and Melone 2006; Grewal et al. 2009; Jenstad et al. 2009) , suggesting that an unidentified neuronal Gln/MeAIB transporter supports Glu transmission in the hippocampus.
Here, the hypothesis that a novel, high-affinity, Ca 2+ -regulated Gln/MeAIB transport system exists in hippocampal neurons is tested; such activity should be optimally regulatable by neuronal activity under physiologic levels of Gln (~30 lM) reported in extrasynaptic space (Kanamori and Ross 2013) . I report that high-affinity, activity-regulated, Ca 2+ -dependent Gln/MeAIB transport exists in hippocampal neurons and that it is inhibited by riluzole, a drug that reduces synaptic release of Glu and Glu-induced excitotoxicity in vitro and in vivo. I also report that both spontaneous and K + depolarization-stimulated Gln/MeAIB transport are dramatically induced between 8 and 20 days in vitro (DIV), which is coordinately regulated with the postnatal maturation of the Glu/Gln cycle (Chowdhury et al. 2007; Hertz 2013) and synaptic vesicular Glu release in cortical and hippocampal neurons in vitro and in vivo (Bolshakov and Siegelbaum 1995; Wasling et al. 2004; De Gois et al. 2005; Wilson et al. 2005) . The identification of activity-regulated, riluzolesensitive, high-affinity neuronal Gln/MeAIB transport emphasizes the importance of this potential therapeutic target in conditions of excessive synaptic release of Glu in hippocampal neurons during development, in mature synapses, and in the aged. A preliminary report of these results has recently appeared (Erickson 2016 ).
Materials and methods

Cell culture
Primary hippocampal neurons were prepared from embryonic day 19 Sprague-Dawley rats (Envigo, Indianapolis, IN, USA. RRID: RGD_5508397) of both sexes (Brewer et al. 1993) . All animal procedures were approved by the Institutional Animal Care and Use Committee at LSUHSC, and complied with the NIH guidelines. Pregnant dams were subjected to an overdose of inhalation of compressed CO 2 administered in an anesthesia chamber and then decapitated using a guillotine. All measures were taken to minimize pain, discomfort, or suffering of animals. Briefly, during dissection the hippocampi were collected in Hanks Balanced Salt Solution (without Ca 2+ ) containing 10 mM MgCl 2 , 10 mM HEPES (pH 7.2), 0.2 mM glutamine, penicillin (100 U/mL), and streptomycin (100 mg/mL) (pen/strep) at 4°C. Hippocampi were then incubated in oxygenated neurobasal medium (NB) without B27 (Invitrogen, Gaithersburg, MD, USA) containing 0.1 mg/mL papain (Sigma, St. Louis, MO, USA) and 0.2 mg/mL cysteine for 15 min at 37°C with shaking. The tissue was transferred to a 15 mL conical tube and allowed to settle and the medium was then replaced twice with Dulbecco's modified Eagle's medium (DMEM) containing 10% (v/ v) fetal bovine serum (FBS). The tissue was then dissociated by trituration with fire-polished Pasteur pipettes in DMEM containing FBS, the cells were counted, diluted in DMEM containing 10% (v/ v) FBS, 0.5 mM glutamax, and 25 lM Glu, and then seeded in sixwell dishes (4 9 10 5 cells/well) pre-coated with 25 lg/mL poly-Dlysine (> 300 000 MW; Sigma). After 2 h at 37°C the medium was removed and replaced with NB medium supplemented with B27, 1% (v/v) FBS, 0.5 mM glutamax, 25 lM Glu, and pen/strep. Cells were maintained at 37°C in a humidified atmosphere containing 5% CO 2 with the addition of 1 mL of NB medium supplemented with B27, 0.5 mM glutamax, and pen/strep every third day of the first week, and every other day thereafter. Astrocyte-enriched cultures were also prepared as secondary cultures from same plating of hippocampal cells as above, except that the cells were maintained in DMEM containing 10% FBS, instead of NB medium. In addition, after 1 week the cells were trypsinized to remove them from the bottom of the flask, and then split 1/10 in DMEM containing 10% FBS and transferred to a new flask. Once confluent, these cells were again split 1/10 in DMEM containing FBS and allowed to reach confluency. Cells were then dispersed (4 9 10 5 /well) in poly-D-lysine-coated six-well clusters for analysis. Astrocytes were treated with high K + depolarization (AE Ca 2+ ) and transport of 14 C-MeAIB (20 lM, 5 min) at 37°C was measured.
Uptake studies Uptake studies were performed using primary neuron-enriched hippocampal cultures at various days of maturation in vitro (DIV). Briefly, cells (most studies were performed at DIV 14) were first rinsed in buffer (3 mL) containing 125 mM NaCl, 4.8 mM KCl, 25 mM HEPES (pH 7.4), 1.2 mM KH 2 PO 4 , 2.5 mM MgSO 4 , 5.6 mM glucose, and 1 mM EGTA (N buffer), and then K + -stimulated (5 min) or spontaneous uptake experiments were performed. Following K + -stimulated or spontaneous Gln/MeAIB uptake, the dishes were removed from the 37°C incubator and placed on ice, and the cells were then washed with ice-cold N buffer (2.5 mL). Sodium dodecyl sulfate (1%, 2 mL) was then added to solubilize the cells and the amount of radioactivity determined by liquid scintillation counting (EcoScint; Nat. Diag., Atlanta, GA C-MeAIB (Perkin-Elmer; 2 ll/well), respectively. For kinetic analysis, various concentrations of unlabeled MeAIB (3.9-500 lM) were added and uptake was terminated at 3 min. Various amino acid substrate competitors (2 mM) were added directly to the radiolabeled 14 C-MeAIB solution and uptake was performed for 5 min. Amino acids tested included: alanine (ala), proline (pro), sarcosine, histidine (his), MeAIB, Gln, leucine (leu), glycine (gly), serine (ser), N'N dimethylglycine, betaine, aminoisobutyric acid, 2-amino-2-norbornane-carboxylic acid, D-serine, arginine (arg), cyclo-D-serine, D-aspartate (D-asp), taurine, and c-aminobutyric acid (GABA). In some experiments verapamil (ver, 20 lM) or tetrodotoxin (TTX, 1 lM) was present during K + stimulation, but they were not present during the 5 min uptake period. For spontaneous uptake experiments N buffer-rinsed cells were bathed (37°C, 5 or 15 min) in (i) N buffer or (ii) N buffer (without EGTA, with 1.2 mM CaCl 2 ) containing 20 lM unlabeled MeAIB spiked with 14 C-MeAIB (2 lL/well). Cells were pre-treated with vehicle (dimethylsulfoxide or water) for control values or with verapamil (20 lM), a-methl-4-carboxyphenylglycine (MCPG, 1 mM), 2-amino-5-phosphonopentanoic acid (50 lM) together with 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]-quinoxaline-7-sulfonamide (10 lM), or TTX (1 lM) 2 min prior to addition of 14 CMeAIB, and these drugs were present during the uptake period. Riluzole (0.039-20 lM) and phenytoin (1.56-200 lM) doseresponse inhibition experiments were performed by pre-incubating cells in Ca 2+ -containing medium with various concentrations of inhibitors (2 min) and then replacing the medium with the same medium (+ drug) containing 20 lM MeAIB.
Data analysis
Uptake of radioactive amino acids was independently measured in culture wells and the final values were derived from at least three independent hippocampal neuronal preparations. Scintillation counts were converted into molar quantities by calculation of specific activity (dpm/pmol) of the radiolabeled/unlabeled Gln or MeAIB mixture used. Error bars represent the means AE SE or means AE SD (for kinetics) of the average values from independent experiments. Comparisons of mean values from 3 to 6 independent neuronal preparations were done by one-way ANOVA with pairwise comparisons between groups adjusted with TukeyKramer post hoc analysis. All non-linear regression analyses were performed in Prism7 (GraphPad Software Inc. La Jolla, CA, USA).
Results
K +
-stimulated, Ca 2+ -dependent Gln transport exists in hippocampal neurons High K + depolarization (56 mM) of axon terminals was the original biochemical method used to show that Gln was a preferred precursor for the Ca 2+ -dependent releasable pool of Glu from hippocampal neurons. An important question that still remains is whether such synaptic activation induces Ca 2+ -dependent Gln transport activity in hippocampal neurons? To examine this question neuron-enriched hippocampal primary cultures were subjected to brief (5 min) high K + depolarization (60 mM) in Ca 2+ -containing KrebsRinger solution, washed in Ca 2+ -free Krebs-Ringer solution containing EGTA (N buffer), and then 3 H-Gln (20 lM) transport was measured in N buffer over 5 min. Uptake in the absence of Ca 2+ or at 4°C was also examined for specificity and to control for non-specific effects. Low concentrations of Gln were used to minimize transport from low-affinity neuronal Gln transporters, such as SNAT1 and SNAT2. We also examined a selective subpopulation of Gln transporters sensitive to inhibition by MeAIB (5 mM). MeAIB-inhibitable 3 H-Gln transport at low concentrations of Gln (20 lM) in the absence of Ca 2+ is low (< 5% of total 3 H-Gln uptake) under Ca 2+ -free spontaneous conditions. However, MeAIB inhibitable and Ca 2+ -dependent 3 HGln uptake increases approximately 25% following a brief exposure to K + depolarization (Fig. 1 ). MeAIB is a transported substrate of the 'classic' system A transporters (Christensen 1990 ) and is not metabolized, which renders it more stable than Gln. Therefore, 14 C-MeAIB (20 lM) was used in all subsequent experiments to identify, and characterize, a subpopulation of Gln/MeAIB transporters that relies on extracellular Ca 2+ ions for functional expression in a whole-cell assay and that is stimulated by K + depolarization. , which is also required for endocytosis (Hosoi et al. 2009 C-MeAIB transport is not observed when Li + ions are substituted for Na + in the uptake buffer (Fig. 3) . The dependence of 14 C-MeAIB transport on the pH of the uptake buffer was also examined and found to be modestly increased at pH 8.2 and decreased at pH 6.0 (Fig. 3) .
Kinetics of K + -induced, Ca 2+ -dependent 14 C-MeAIB transport activity differentiate this neuronal transport system from SNAT1-or SNAT2-mediated activity, which display much lower affinity (K m~0 .5 mM ) do not transport significant amounts of 14 C-MeAIB (20 lM, 5 min, 37°C). Data are the mean AE SE for n = 3 independent experiments. F 7,24 = 25.5, p < 0.01 (main effect) **p < 0.001. affinity (K m ) for MeAIB of 37 AE 1.2 lM and saturates at 200 lM (Fig. 4) . The relative ability of various amino acid substrates at 2 mM to block K + -induced/Ca 2+ -dependent 14 CMeAIB transport, which is indicative of relative substrate affinity of the transporter, is shown in Fig. 5 . Amino acids tested include alanine, proline, sarcosine, histidine, MeAIB, Gln, leucine, glycine, serine, N'N-dimethylglycine, betaine, aminoisobutyric acid, 2-amino-2-norbornanecarboxylic acid, D-serine, arginine, cyclo-D-serine, D-aspartic acid, taurine, and c-aminobutyric acid (GABA). The preferred substrate competitors alanine, proline, sarcosine, histidine, MeAIB, and Gln displayed greater than 90% inhibition of 14 C-MeAIB transport when present at 2 mM concentration (Fig. 5) . Taurine, GABA, cyclo-D-serine, and D-aspartic acid do not interfere with K + -stimulated transport of MeAIB. Activity-induced, Ca 2+ -dependent MeAIB transport is not observed in cultured hippocampal astrocytes (Fig. 2) . High K + was used here to maximally depolarize axon terminals, which is reasonable for the initial screen to identify the substrates and inhibitors and kinetically characterize this novel high-affinity Ca 2+ -dependent Gln/MeAIB transport system in primary hippocampal neurons. (Figs 1 and 2) . Spontaneous, Ca 2+ -dependent 14 C-MeAIB transport is blocked by TTX (1 lM), an inhibitor of Na + channels that are required for action-potential-mediated Ca 2+ -stimulated exocytosis of Glu and neural circuit activity (Fig. 6) , unlike K + -stimulated transport. Spontaneous transport does not occur with Li + ions substituted for Na + (not shown). Transport is dependent on excitatory-driven neural circuit activity because it is blocked by inhibitors of a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid and NMDA Glu receptors that mediate postsynaptic Glu transmission (Fig. 6) . Spontaneous transport is not affected by MCPG (Fig. 6 ), a group I/II metabotropic Glu receptor inhibitor. Spontaneous MeAIB transport is inhibited by high concentrations (2 mM) of GABA (Fig. 6) , which activates GABA receptors to increase inhibitory transmission and shunt Glu-driven neural circuit activity. Together, these results indicate that a Ca 2+ -dependent Gln/ MeAIB transporter exists spontaneously in hippocampal neuronal cultures and requires Na + -and Ca 2+ -dependent Glu transmission for functional activity.
Spontaneous
Alanine, proline, sarcosine, histidine, MeAIB, and Gln display greater than 90% inhibition of 14 C-MeAIB transport when present at 2 mM concentration (Fig. 6) , which indicates that they are also preferred potential substrates for spontaneous Ca 2+ -dependent 14 C-MeAIB transport, like they are for K + -stimulated transport. Gln is present at much greater levels in extrasynaptic space in vivo, compared to all other amino acids. Taurine, an osmolyte and regulator of Ca 2+ homeostasis in neurons, does not interfere with 14 C-MeAIB transport (Fig. 6 ). Together these results indicate that a Ca 2+ -regulated, Gln-sensitive MeAIB transporter exists spontaneously in primary neuron-enriched hippocampal cultures.
Spontaneous, Ca
2+ -regulated MeAIB transport is potently inhibited by riluzole, a neuroprotective agent Riluzole is neuroprotective in conditions of excessive synaptic Glu release because it inhibits Glu release from synapses. Does riluzole inhibit activity-regulated Gln/ MeAIB import into hippocampal neurons? To examine this question, neurons were pre-incubated with riluzole or other potential anti-glutamatergic agents for 2 min in Ca 2+ -containing Krebs buffer and then with same medium containing 14 C-MeAIB (20 lM) for 15 min. Drugs examined are anti-glutamatergic agents used in epilepsy, global and focal ischemic stroke, amyotrophic lateral sclerosis, or Glu-induced hearing loss that include riluzole, lamotrigine, phenytoin, carbazepam, topiramate, ethosuximide, valproic acid, Gabapentin, zonasamide, and levetiracetam. At 20 lM concentration, riluzole completely blocks spontaneous Ca 2+ -dependent MeAIB transport, whereas lamatrogine, phenytoin, and toperimate were much less effective inhibiting approximately 54%, 25%, and 20% of control values, respectively. The relative inhibitory constant (IC 50 ) for riluzole to inhibit spontaneous Ca 2+ -dependent MeAIB transport is 1.3 AE 0.1 lM (Fig. 7) . Phenytoin displays an IC 50 value of 57 AE 4 lM to block activity-regulated, Ca 2+ -dependent, high-affinity Gln/MeAIB transport in hippocampal neuronal cultures (Fig. 7) , which is 509 less potent than riluzole. All other agents tested are ineffective at 20 lM concentration. The relative potency values for riluzole and phenytoin described here are consistent with the reported differences between riluzole and phenytoin to provide neuroprotection against pre-synaptic Glu-induced excitotoxicity in acute and chronic neurodegenerative conditions. Collectively, these results demonstrate that activity-dependent, Ca 2+ -regulated Gln/MeAIB transport is developmentally up-regulated during the critical period of maturation of glutamatergic pre-synaptic strength and is maximally expressed in fully differentiated, mature hippocampal neurons.
Discussion
This report describes, for the first time, a high-affinity, Ca 2+ -regulated, K + -stimulated, and spontaneously active Gln/ MeAIB transport system in hippocampal neuron-enriched primary cultures that is regulated endogenously by neuronal activity in mature synapses, potently inhibited by riluzole (a blocker of Glu release), and that is up-regulated during the critical postnatal period of functional maturation of the Glu/ Gln cycle between astrocytes and neurons and synaptic Glu release. The novel Gln/MeAIB transport system described (DIV 8, 12, 14, 16, and 20 inclusion of MeAIB (5 mM). Background levels at 4°C are consistently at < 50 pmol/well. MeAIB (5 mM) subtracted data are the mean AE SE values from n = 3 independent experiments. F 9,72 = 481, p < 0.0001 (main effect). *p < 0.05, **p < 0.001.
here may have physiological and pathological implications in understanding the neurobiology of excitotoxic synaptic Glu release in the hippocampus in acute and chronic neurodegenerative diseases. Gln transport is robust in hippocampal neurons as a result of the multitude of Gln transporter subtypes (at least 14) that exist in the CNS that subserve multiple physiologic functions in many cellular compartments (Albrecht et al. 2007; Schioth et al. 2013) . However, only a small percentage (< 5%) of the total amount of Gln transported in hippocampal neuronal culture (5 min at 20 lM 3 H-Gln concentration) is sensitive to inhibition by MeAIB (5 mM), a selective blocker of system A transport (Christensen 1990; McGivan and Pastor-Anglada 1994) . However, Ca 2+ -dependent MeAIB-sensitive Gln transport activity can be stimulated by brief high K + depolarization of axon terminals suggesting that an activity-regulated Ca 2+ -dependent Gln/MeAIB transporter exists in hippocampal neurons. The transport of MeAIB was therefore used here as a specific substrate to isolate and to further characterize this Gln transporter subpopulation, and because MeAIB is not metabolized, and so is more stable than Gln. As surmised, Ca 2+ -dependent transport of MeAIB is greatly stimulated following brief K + depolarization. K + -stimulated MeAIB transport is dependent on extracellular Ca 2+ , and in the presence of 1.2 mM Ca 2+ , MeAIB transport is blocked by inhibition of voltage-gated calcium channels (verapamil, 20 lM) . This K + depolarization-induced Gln/MeAIB transport system displays relatively high affinity for MeAIB (37 AE 1.2 lM) and is maximally active at MeAIB concentrations of 200 lM, unlike lowaffinity (K m~0 .5 mM) neuronal Gln/MeAIB transporters SNAT1 or SNAT2 (Mackenzie and Erickson 2004) . The novel, high-affinity Gln transporter in hippocampal neurons described here would operate efficiently at low extrasynaptic levels of Gln (~30 lM) reported in the hippocampus in vivo (Kanamori and Ross 2013) , which would be ideal for activity-dependent regulation of Gln cycling into synapses. Whereas other precursors could contribute to regulating cytoplasmic Glu levels and vesicular Glu stores in cortical and hippocampal axon terminals (Hassel and Brathe 2000; Lieth et al. 2001; Kam and Nicoll 2007; Takeda et al. 2012) , Gln is still considered the preferred precursor for loading the Ca 2+ -dependent releasable pool of vesicular Glu (Leke and Schousboe 2016) .
This study challenges existing research paradigms that the known low-affinity neuronal Gln/MeAIB transporters SNAT1 or SNAT2 are involved in supplying Gln at synapses for Glu transmission (Chaudhry et al. 2002; Mackenzie and Erickson 2004; Conti and Melone 2006) . A higher-affinity Gln/MeAIB transport system that is regulated by neuronal activity, and inhibited by riluzole, is a potential new target to affect pre-synaptic Glu transmission in hippocampal neurons. MeAIB is a substrate competitor for several other amino acid transporters as well, such as the lysosomal amino acid transporter LYAAT-1 (Sagne et al. 2001) , the electrogenic H + -dependent amino acid co-transporter proton-dependent amino acid co-transporter 2 (Boll et al. 2002) , the synaptic vesicle-enriched amino acid transporter NTT4/Rxt1 (Zaia and Reimer 2009) , and a broad-spectrum amino acid transporter SNAT8 (Hagglund et al. 2015) . Gln uptake by neuronal SNAT7 and SNAT8 isoforms is weak in oocytes and they may also transport cationic and anionic amino acids (Hagglund et al. 2011 (Hagglund et al. , 2015 . NTT4/Rxt1 is found in preparations enriched in synaptic vesicles (Masson et al. 1999) and recently was described to be a leu/pro/his/Gln/ MeAIB transporter when molecularly engineered for expression at the plasma membrane (Zaia and Reimer 2009 C-MeAIB transport may also, of course, be still an orphan or a misidentified Slc member.
Low levels of Ca 2+ -regulated Gln/MeAIB transport described in this study could be a result of the intracellular sequestration of an inducible, Ca 2+ -dependent recycling of a high-affinity Gln/MeAIB transporter protein in excitatory synapses providing an important regulatory mechanism for activity-regulated Glu transmission. Indeed, regulated cycling of transporters involved in the recycling of other neurotransmitters, such as acetylcholine and GABA, relies on cycling of intracellular pools of high-affinity choline transporter and GABA transporter (GAT1) to the plasma membrane in nerve terminals (Deken et al. 2003; Ferguson et al. 2003; Ribeiro et al. 2007) . SNAT2 is also regulated at the level of recycling of an intracellular pool of SNAT2 vesicles in many cell types as an osmolyte (Franchi-Gazzola et al. 2006) including neurons, but is not required for pre-synaptic Glu transmission in cortical neurons in vitro (Grewal et al. 2009 ). The dependence of spontaneous Ca 2+ -regulated MeAIB transport on Na + (TTX inhibitable, Li + intolerant), Ca 2+ (voltage-gated calcium channel inhibitable), and post-synaptic Glu receptor function (2,3-dioxo-6nitro-1,2,3,4-tetrahydrobenzo[f]-quinoxaline-7-sulfonamide/2-amino-5-phosphonopentanoic acid inhibitable) described here indicates the requirement for actionpotential-stimulated and Glu-driven neural circuit activity. Blockade of endogenous synaptic Glu transmission by inclusion of GABA, to increase synaptic inhibition, also blocks spontaneous Ca 2+ -regulated MeAIB transport. Collectively these results support the presence of intracellular stores of a high-affinity Gln/MeAIB transporter protein in hippocampal neurons that exhibits Ca 2+ -dependent cycling to the plasma membrane for functional expression and that is inducible by neuronal activity.
Biochemical studies and 13 C-NMR determinations have similarly identified the time period during which the Glu/Gln cycle activity develops in the rat to between postnatal days 10 and 30 (Chowdhury et al. 2007; Hertz 2013) . Presynaptic Glu release and Glu transmission also increases dramatically in pyramidal neurons during this time period in vivo and in vitro (Bolshakov and Siegelbaum 1995; Wasling et al. 2004; De Gois et al. 2005; Wilson et al. 2005) . In this study, spontaneous and K + -stimulated Gln/ MeAIB transport is negligible in DIV 8 cultures but is maximal (> 10-fold increase) by DIV 20. The developmental period selected for neuronal experiments to investigate the role for regulated Gln/MeAIB transport in excitatory transmission is therefore critical. Gln transport during this 'critical' period of postnatal development may contribute in mechanisms of synaptic growth and differentiation. Synaptic growth, re-organization, and plasticity may require Gln because activity-dependent Gln transport could facilitate presynaptic Glu release that strengthens selective excitatory synaptic pathways in the brain. For instance, Glu-dependent secretion of brain-derived neurotrophic factor (BDNF) sculpts cortical and hippocampal neural circuits during development (Lu 2003; Kuczewski et al. 2010; Park and Poo 2013) , stimulates energy metabolism (Burkhalter et al. 2003) , and regulates Gln/MeAIB-sensitive dendritic development (Burkhalter et al. 2007 ). Thus, activity-regulated synaptic Gln transport during development may facilitate proper establishment of synaptic Glu release in neural circuits for the development of stable neural networks.
The inhibition of spontaneous Gln/MeAIB transport by riluzole suggests that neural activity regulated Gln/MeAIB transport may be linked to Na + -dependent/action-potentialdriven and Ca 2+ -regulated synaptic release of Glu. Riluzole has been shown to inhibit synaptic Glu release (Martin et al. 1993; Kretschmer et al. 1998; Lingamaneni and Hemmings 1999; Wang et al. 2004) . Neuroprotection by riluzole may occur by inhibiting Glu release in neurons via mechanisms that include inhibition of Na + channels (Benoit and Escande 1991; Martin et al. 1993; Herbert et al. 1994; Stefani et al. 1997; Prakriya and Mennerick 2000; Spadoni et al. 2002) . Riluzole inhibition of Na + channels would reduce actionpotential-driven neuronal circuit activity and, thus, synaptic Glu release that drives a-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor mediated Glu activity and subsequent NMDA-mediated excitotoxicity. Phenytoin, an established Na + channel blocker, also blocks activityregulated Gln/MeAIB transport, and both riluzole and phenytoin are neuroprotective in ischemia-induced neuronal death in vivo (Malgouris et al. 1989; Taft et al. 1989; Pratt et al. 1992; Ates et al. 2013) . However, riluzole is more than 509 more potent than phenytoin to inhibit activity-regulated Gln/MeAIB transport, which agrees with its improved potency to prevent excitotoxic Glu-induced neuronal damage in the hippocampus (Ates et al. 2013) . These results support the development of selective riluzole-derived drugs to target neural-regulated Gln/MeAIB transport activity for neuroprotection.
A recent quantitative analysis of the rates of release and resupply of vesicular Glu required to sustain synaptic Glu release confirms that maintaining the synaptic cytoplasmic Glu supply via Gln released from glia is essential for continued Ca 2+ -dependent synaptic Glu release under conditions of increased neural activity (Marx et al. 2015) . Excessive and sustained synaptic release of Glu is an initial event that triggers Ca 2+ -dependent Glu-mediated cell death in post-synaptic neurons in various deleterious conditions including traumatic brain injury, peri-operative neuronal and cardiac stress, epilepsy, global and focal cerebral ischemia, mild Alzheimer's disease, noise-induced hearing loss, and in several in vitro models of neurodegenerative diseases including oxygen-glucose reperfusion injury (Bittigau and Ikonomidou 1997; Dodd 2002; Holmes 2002; Kostandy 2012; Dorsett et al. 2016; Mancini et al. 2016; Pereira et al. 2016) . Riluzole is neuroprotective in all of these acute and chronic neurodegenerative conditions (Malgouris et al. 1989; Pratt et al. 1992; Bae et al. 2000; Ruel et al. 2005; Heurteaux et al. 2006; Hunsberger et al. 2015; Pereira et al. 2016; Verma et al. 2016) . Riluzole is more effective as a neuroprotective agent when given prophylactically, which is in line with its presumed role to reduce synaptic Glu release and resultant Glu-induced excitotoxicity post-synaptically. The identification of Ca 2+ -regulated, riluzole-sensitive, highaffinity Gln/MeAIB transport in hippocampal neurons supports a role for an activity-regulated Gln transporter in regulating Glu release from synapses and resulting synaptic Glu-induced excitotoxicity.
